BRIEF published on 10/24/2024 at 07:35, 1 year 8 months ago Rentschler Biopharma's Major Investment in German Headquarters Investment Rentschler Biopharma Biopharmaceuticals Facility Expansion Laupheim
PRESS RELEASE published on 10/24/2024 at 07:30, 1 year 8 months ago Rentschler Biopharma announces largest single investment at its headquarters in Germany Rentschler Biopharma announces largest single investment at its headquarters in Germany to construct a new buffer media facility, enhancing production efficiency and sustainability Innovation Investment Germany Rentschler Biopharma Biopharmaceuticals
BRIEF published on 09/03/2024 at 13:05, 1 year 9 months ago Rentschler Biopharma présente une nouvelle boîte à outils de fabrication de vecteurs lentiviraux Thérapie Génique Produits Biopharmaceutiques Thérapies Avancées Vecteurs Lentiviraux Services De Fabrication
BRIEF published on 09/03/2024 at 13:05, 1 year 9 months ago Rentschler Biopharma Introduces New Lentiviral Vector Manufacturing Toolbox Gene Therapy Advanced Therapies Biopharmaceuticals Lentiviral Vectors Manufacturing Services
PRESS RELEASE published on 09/03/2024 at 13:00, 1 year 9 months ago Rentschler Biopharma introduces new lentiviral vector manufacturing toolbox for advanced therapies Rentschler Biopharma launches new lentiviral vector manufacturing toolbox for advanced therapies at UK site, enhancing advanced therapy offerings Gene Therapy Advanced Therapies Rentschler Biopharma Lentiviral Vector Manufacturing Toolbox
BRIEF published on 07/11/2024 at 14:05, 1 year 11 months ago Rentschler Biopharma Unveils New Production Line in Massachusetts Rentschler Biopharma Biopharmaceuticals Massachusetts Production Line
BRIEF published on 07/11/2024 at 14:05, 1 year 11 months ago Rentschler Biopharma dévoile une nouvelle ligne de production dans le Massachusetts Rentschler Biopharma Produits Biopharmaceutiques Massachusetts Ligne De Production
PRESS RELEASE published on 07/11/2024 at 14:00, 1 year 11 months ago Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational Rentschler Biopharma SE announces full operational status of new state-of-the-art production line in Massachusetts, marking largest expansion in company's history Expansion Manufacturing Biopharmaceuticals Rentschler Biopharma SE State-of-the-art Production Line
BRIEF published on 05/28/2024 at 13:05, 2 years 1 month ago Rentschler Biopharma nomme Patrick Meyer au poste de responsable mondial des ventes et de la gestion des alliances BD Rentschler Biopharma Produits Biopharmaceutiques Développement Des Affaires Patrick Meyer
BRIEF published on 05/28/2024 at 13:05, 2 years 1 month ago Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer
Published on 07/01/2026 at 17:00, 5 hours 35 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 07/01/2026 at 14:30, 8 hours 5 minutes ago AIAI Holdings' MediGuide Launches Digital Platform
Published on 07/01/2026 at 13:30, 9 hours 5 minutes ago Sidney Resources Corporation Appoints Former Idaho Governor C.L. "Butch" Otter as Chairman of the Board
Published on 07/01/2026 at 13:00, 9 hours 35 minutes ago Fox River Issues Shares Pursuant to Exploration Agreement in Connection with Impending Arrangement
Published on 07/01/2026 at 03:15, 19 hours 20 minutes ago GLG Life Tech Corporation Announces 2026 AGM Voting Results
Published on 07/01/2026 at 20:40, 1 hour 55 minutes ago KNDS to resume its Initial Public Offering process when Capital Markets conditions are supportive
Published on 07/01/2026 at 20:04, 2 hours 30 minutes ago 2CRSi SA: 2CRSi engage une procédure de vérification indépendante relative à son contrat allemand.
Published on 07/01/2026 at 20:04, 2 hours 30 minutes ago 2CRSi SA: 2CRSi initiates an independent verification procedure regarding its German contract.
Published on 07/01/2026 at 19:00, 3 hours 35 minutes ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 07/01/2026 at 19:00, 3 hours 35 minutes ago OLB strengthens its leadership team to drive the next phase of growth
Published on 07/01/2026 at 19:40, 2 hours 54 minutes ago Initiation de couverture du titre Solocal par Portzamparc
Published on 07/01/2026 at 18:26, 4 hours 9 minutes ago Modula renews its confidence in AMA with a four-year agreement integrating XpertEye’s new AI-powered features
Published on 07/01/2026 at 18:26, 4 hours 9 minutes ago Modula renouvelle sa confiance à AMA avec un contrat de quatre ans intégrant les nouvelles fonctionnalités IA d’XpertEye
Published on 07/01/2026 at 18:01, 4 hours 34 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
